Shanghai Chest Hospital: Esophageal Neoplasms trials

The registry lists 13 Esophageal Neoplasms studies with Shanghai Chest Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ ECNot yet recruitingNCT06965829Phase 2
• Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)RecruitingNCT06385730Phase 2
• Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic EvaluationRecruitingNCT06348381
• Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal CancerRecruitingNCT06173986Phase 1/2
• Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell CarcinomaRecruitingNCT05978193Phase 2
• Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell CarcinomaRecruitingNCT04135664Phase 3
• Shanghai Clinical Cohort - Esophageal CancerCompletedNCT07312526
• Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)Active, not recruitingNCT05621707Phase 2
• Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal CancerStatus unknownNCT04984096
• Pre-Surgery If Needed for Oesophageal CancerCompletedNCT03937362
• Robot-assisted Esophagectomy Versus Conventional Thoracoscopic EsophagectomyStatus unknownNCT03094351Phase 3
• Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal CancerStatus unknownNCT02938195Phase 2
• Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal CancerStatus unknownNCT02891083Phase 3